Insider Transactions in Q2 2018 at Kezar Life Sciences, Inc. (KZR)
Insider Transaction List (Q2 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 25
2018
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+13.71%
|
$3,750,000
$15.0 P/Share
|
|
Jun 25
2018
|
Cormorant Asset Management, LP > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,322,909
+46.62%
|
-
|
|
Jun 25
2018
|
Onyx Therapeutics, Inc. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,121,384
+50.0%
|
-
|